Major Liver Resection in Cirrhotic HCC Patients in the Era of Robotic Surgery: Expanding Boundaries of Surgical Therapy
British Journal of Surgery · 03.06.2026 · 113 (Supplement_5)
DOI: 10.1093/bjs/znag055.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 03.06.2026. Verfasst von P Kambakamba und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Cirrhosis has traditionally been considered a relative contraindication for hepatic resection due to the risk of post-hepatectomy liver failure (PHLF). With the rising incidence of HCC and persistent organ shortage, alternative curative approaches are urgently required. Robotic surgery may provide improved outcomes, less invasiveness, and be particularly beneficial for cirrhotic patients.
Aims
To evaluate the safety and outcomes of robotic liver resection in cirrhotic HCC patients.
Methods
We retrospectively analyzed all cirrhotic patients with HCC undergoing liver resection between 2020–2025. Patients were stratified by approach (open, laparoscopic, robotic).
Results
Fifty-seven (n=57) cirrhotic patients underwent liver resection for HCC: open (n=28), laparoscopic (n=7), and robotic (n=21). Whereas initially major resections accounted only for 17% (n=6/35) of open and laparoscopic resections, the initiation of the robotic program significantly increased the rate of major resections up to 43% (n=9/21). Despite a learning curve, overall median operative time was comparable between open and robotic resections (242 vs. 252 minutes, p=0.64), whereas robotic procedures significantly reduced operation time compared with equivalent laparoscopic resections from 214 to 198 minutes (p=0.03). With proportional increase of major liver resections, a trend to bigger tumor size and frameshift from BCLC 0 to BCLC A patients was observed for the robotic group. In that context, PHLF occurred in n=3/6 robotic major resections (all ISGLS grade A, resolved with supportive care) versus n=2/9 severe grade C cases after open surgery. Despite more complex resections, robotic patients had shorter ICU stay (1 vs. 3 days, p=0.01) and reduced hospital stay (7 vs. 11 days, p=0.02). No conversion and no mortality occured for robotic resections. R0 rates were comparable (98% vs. 96%, p=0.89).
Conclusion
Robotic hepatectomies are safe in selected cirrhotic HCC patients. Although mild PHLF was common, recovery outcomes are favorable. Therfore, in the era of organ shortage, robotic surgery can expand resectional options.
Zitieren
APA
Kambakamba, P., & Farkas, S. (2026). Major Liver Resection in Cirrhotic HCC Patients in the Era of Robotic Surgery: Expanding Boundaries of Surgical Therapy. British Journal of Surgery, 113(Supplement_5). https://doi.org/10.1093/bjs/znag055.034
Vancouver
Kambakamba P, Farkas S. Major Liver Resection in Cirrhotic HCC Patients in the Era of Robotic Surgery: Expanding Boundaries of Surgical Therapy. British Journal of Surgery. 2026;113(Supplement_5). doi:10.1093/bjs/znag055.034
BibTeX
@article{Kambakamba2026,
author = {Kambakamba, P and Farkas, S},
title = {Major Liver Resection in Cirrhotic HCC Patients in the Era of Robotic Surgery: Expanding Boundaries of Surgical Therapy},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_5},
doi = {10.1093/bjs/znag055.034}
}
EUVIMED